Mark Pacyna is the founder of Reprieve Cardiovascular. Reprieve Cardiovascular has raised $103M in total funding. Latest round: Series B.
Mark Pacyna is the CEO of Reprieve Cardiovascular, a clinical-stage medical device company focused on decongestion management therapy for acute decompensated heart failure. He announced the company's emergence from stealth after a $42 million financing and led a $61 million Series B round. Pacyna has also represented the company at healthcare conferences to discuss clinical trial progress.
Full founder directory · Investor directory · Company funding database · Fundraising library